Estimaciones de analistas de Wall Street para Co-Diagnostics, Inc. (CODX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 2 |
| Mantener | 3 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 5 |
| Calificación media (1-5) | 0.40 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-16 | $-1.25 | ||
| 2026-08-13 | $-1.46 | $-3.00 | +51.3% |
| 2026-05-14 | $-4.06 | $-3.75 | -8.3% |
| 2026-03-31 | $-16.35 | $-3.60 | -354.2% |
| 2025-11-13 | $-4.80 | $-5.71 | +15.9% |
| 2025-08-14 | $-6.91 | $-7.51 | +8.0% |
| 2025-05-08 | $-7.21 | $-8.10 | +11.0% |
| 2025-03-27 | $-10.81 | $-0.33 | -3175.8% |
Ratios de valoración
| Precio / Valor contable | 0.30 |
| EV / EBITDA | 0.01 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $7662 | $39911 | $214974 | $74.6M | $97.9M | $34.2M | $6.8M | $3.9M | $622489 |
| Coste de Ventas | $37491 | $302 | $9391 | $112431 | $16.6M | $11.6M | $5.5M | $4.2M | $999124 | $222377 |
| Beneficio Bruto | -$37491 | $7360 | $30520 | $102543 | $58.0M | $86.3M | $28.7M | $2.6M | $2.9M | $400112 |
| I+D | $731474 | $1.0M | $1.4M | $1.4M | $3.2M | $15.0M | $17.4M | $23.0M | $21.0M | $19.1M |
| Generales y Administrativos | $919000 | $3.5M | $4.7M | $4.6M | $12.9M | $24.9M | $21.6M | $21.1M | $20.6M | $11.4M |
| Gastos Operativos | $1.7M | $4.6M | $6.1M | $6.0M | $16.3M | $40.2M | $55.7M | $45.3M | $43.0M | $31.7M |
| Beneficio Operativo | -$1.7M | -$4.6M | -$6.1M | -$5.9M | $41.7M | $46.1M | -$27.0M | -$42.7M | -$40.1M | -$31.3M |
| EBITDA | -$1.7M | -$6.6M | -$6.1M | -$6.0M | $41.8M | $46.0M | -$10.3M | -$36.9M | -$36.2M | -$47.4M |
| Gastos por Intereses | $240720 | $310233 | $134947 | $106437 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.9M | -$7.0M | -$6.3M | -$6.2M | $42.6M | $45.6M | -$18.8M | -$38.1M | -$37.6M | -$48.5M |
| Impuestos | 0 | 0 | -$18960 | 0 | $90536 | $9.0M | -$4.6M | -$2.8M | $57368 | -$1.6M |
| Beneficio Neto | -$1.9M | -$7.0M | -$6.3M | -$6.2M | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | -$46.9M |
| BPA | $-5.10 | $-18.90 | $-15.00 | $-11.09 | $1.59 | $38.10 | $-13.57 | $-36.00 | $-37.20 | $-35.25 |
| BPA Diluido | $-5.10 | $-18.90 | $-15.00 | $-11.09 | $1.52 | $36.90 | $-13.57 | $-36.00 | $-37.20 | $-35.25 |
| Acciones en Circulación (Diluidas) | $372739 | $365344 | $416154 | $558564 | $933345 | $996790 | $1.0M | $978220 | $1.0M | $1.3M |
Precio
| Precio | $0.94 |
| Capitalización | $1M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADGM · AEMD · ALUR · DWTX · NVNO · PRPH · SINT
Explorar sector: Healthcare · Biotechnology
Más secciones de CODX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones